These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 36530613)

  • 1. Efficacy and safety of hypoglycemic drugs in improving cognitive function in patients with Alzheimer's disease and mild cognitive impairment: A systematic review and network meta-analysis.
    Wang XC; Chu CL; Li HC; Lu K; Liu CJ; Cai YF; Quan SJ; Zhang SJ
    Front Neurol; 2022; 13():1018027. PubMed ID: 36530613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy and safety of anti-Aβ agents for delaying cognitive decline in Alzheimer's disease: a meta-analysis.
    Li J; Wu X; Tan X; Wang S; Qu R; Wu X; Chen Z; Wang Z; Chen G
    Front Aging Neurosci; 2023; 15():1257973. PubMed ID: 38020763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of rTMS treatment on global cognitive function in Alzheimer's disease: A systematic review and meta-analysis.
    Zhang T; Sui Y; Lu Q; Xu X; Zhu Y; Dai W; Shen Y; Wang T
    Front Aging Neurosci; 2022; 14():984708. PubMed ID: 36158564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Electronic Serious Games on Older Adults With Alzheimer's Disease and Mild Cognitive Impairment: Systematic Review With Meta-Analysis of Randomized Controlled Trials.
    Zuo X; Tang Y; Chen Y; Zhou Z
    JMIR Serious Games; 2024 Jul; 12():e55785. PubMed ID: 39083796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Efficacy and Safety of Monoclonal Antibodies for Cognitive Decline in Patients with Alzheimer's Disease: A Systematic Review and Network Meta-Analysis.
    Qiao Y; Gu J; Yu M; Chi Y; Ma Y
    CNS Drugs; 2024 Mar; 38(3):169-192. PubMed ID: 38429615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of monoclonal antibodies against amyloid-β on clinical and biomarker outcomes and adverse event risks: A systematic review and meta-analysis of phase III RCTs in Alzheimer's disease.
    Avgerinos KI; Ferrucci L; Kapogiannis D
    Ageing Res Rev; 2021 Jul; 68():101339. PubMed ID: 33831607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial.
    Wilcock GK; Black SE; Hendrix SB; Zavitz KH; Swabb EA; Laughlin MA;
    Lancet Neurol; 2008 Jun; 7(6):483-93. PubMed ID: 18450517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcranial magnetic stimulation effects on cognitive enhancement in mild cognitive impairment and Alzheimer's disease: a systematic review and meta-analysis.
    Yan Y; Tian M; Wang T; Wang X; Wang Y; Shi J
    Front Neurol; 2023; 14():1209205. PubMed ID: 37528850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cognitive effect of non-invasive brain stimulation combined with cognitive training in Alzheimer's disease and mild cognitive impairment: a systematic review and meta-analysis.
    Yang T; Liu W; He J; Gui C; Meng L; Xu L; Jia C
    Alzheimers Res Ther; 2024 Jun; 16(1):140. PubMed ID: 38937842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of acupuncture for cognitive impairment in Alzheimer's disease: a systematic review and meta-analysis.
    Guo R; Shen X; Ealing J; Zhou J; Lu J; Ning Y
    Front Dement; 2024; 3():1380221. PubMed ID: 39081600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rivastigmine for Alzheimer's disease.
    Birks JS; Grimley Evans J
    Cochrane Database Syst Rev; 2015 Apr; (4):CD001191. PubMed ID: 25858345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy of statins in the treatment of Alzheimer's disease: a meta-analysis of randomized controlled trial.
    Xuan K; Zhao T; Qu G; Liu H; Chen X; Sun Y
    Neurol Sci; 2020 Jun; 41(6):1391-1404. PubMed ID: 31930449
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Zhang Y; Tian J; Ni J; Wei M; Li T; Shi J
    Front Pharmacol; 2023; 14():1268000. PubMed ID: 38283842
    [No Abstract]   [Full Text] [Related]  

  • 14. The value of cholinesterase inhibitors for improving neuropsychiatric and functional assessment scores in patients with Alzheimer disease: a systematic review and meta-analysis of on placebo-controlled RCTs.
    Zhang Y; Sun Y; Hu X; Yao Y; Wang J
    Int J Surg; 2024 Jun; 110(6):3937-3945. PubMed ID: 38573101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of vitamins B supplementation on mild cognitive impairment and Alzheimer's disease: a systematic review and meta-analysis.
    Li MM; Yu JT; Wang HF; Jiang T; Wang J; Meng XF; Tan CC; Wang C; Tan L
    Curr Alzheimer Res; 2014; 11(9):844-52. PubMed ID: 25274113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Comparative Efficacy of Multiple Interventions for Mild Cognitive Impairment in Alzheimer's Disease: A Bayesian Network Meta-Analysis.
    Lai X; Wen H; Li Y; Lu L; Tang C
    Front Aging Neurosci; 2020; 12():121. PubMed ID: 32581760
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy of intranasal insulin in improving cognition in mild cognitive impairment or dementia: a systematic review and meta-analysis.
    Long C; Han X; Yang Y; Li T; Zhou Q; Chen Q
    Front Aging Neurosci; 2022; 14():963933. PubMed ID: 36172480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evidence of hyperbaric oxygen therapy for Alzheimer's disease: a systematic review and meta-analysis of randomized controlled trials.
    Lin G; Zhao L; Lin J; Li X; Xu L
    Front Aging Neurosci; 2024; 16():1360148. PubMed ID: 38577491
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.